Somatek is attending 2023 BioProcess International US West. The conference takes place from February 27 – March 2 at the San Diego Convention Center under the headline ACCELERATE SPEED TO MARKET FOR YOUR NEXT GENERATION MABS, VACCINES AND CELL/GENE THERAPY...
This post and a huge thank you to David Sergeant and Justin Foox of Ipratech has been overdue for some time. Early last year, Somatek acquired a CYTOSYS control platform for its process development work. Having experience with bioreactor controllers from several other...
The Janssen Pharmaceutical Companies of Johnson & Johnson, together with a consortium of global partners, on Wednesday announced the results of an independent, scheduled data review of the Phase 3 Mosaico study of Janssen’s investigational HIV vaccine regimen. The...
The Somatek team looks forward to continuing productive and enjoyable collaborations in 2023. Happy New Year to all our friends and customers! Barbara, Branda, Dave, Gina, Guillermo, JT, Katie, Maddy, Mark, Sierra and Stephanie
